Alzheimer, xenon gas

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Butovsky believes xenon has potential as an AD treatment. A Phase 1 clinical trial of xenon at BWH is recruiting healthy elderly volunteers to test safety and effects on immune cells. “I hope this ...
This spring, a group of commercial climbers plan to summit Everest in just a week by chemically boosting their ...
Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research has found. The findings provide new hope in the battle against this devastating disorder.